We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
-3.48%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$85.2B
AUM Growth
+$4.83B
Cap. Flow
+$8.98B
Cap. Flow %
10.54%
Top 10 Hldgs %
12.02%
Holding
4,686
New
822
Increased
1,556
Reduced
1,625
Closed
650

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$786M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$409M
3
MU icon
Micron Technology
MU
+$379M
4
T icon
AT&T
T
+$372M
5
MDT icon
Medtronic
MDT
+$370M

Sector Composition

Rank Sector Weight
1 Healthcare 18.69%
2 Technology 14.95%
3 Consumer Discretionary 11.34%
4 Consumer Staples 10.7%
5 Communication Services 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTX icon
3926
Context Therapeutics
CNTX
$46.5M
$44K ﹤0.01%
20,309
-44,309
-69% -$93.2K
TPHS
3927
DELISTED
Trinity Place Holdings Inc.com
TPHS
$44K ﹤0.01%
22,929
-11,451
-33% -$21.1K
CALC icon
3928
CalciMedica
CALC
$20.2M
$43K ﹤0.01%
2,524
+1,738
+221% +$33.1K
CREX icon
3929
Creative Realities
CREX
$44M
$43K ﹤0.01%
17,633
-38,251
-68% -$135K
IDN icon
3930
Intellicheck
IDN
$75.9M
$43K ﹤0.01%
+16,897
New +$61.6K
INM icon
3931
InMed Pharmaceuticals
INM
$7.64M
$43K ﹤0.01%
90
+2
+2% +$1.05K
SINT icon
3932
SiNtx Technologies
SINT
$10.9M
$42K ﹤0.01%
3
+1
+50% +$10.6K
RENO
3933
DELISTED
Renovare Environmental, Inc. Common Stock
RENO
$41K ﹤0.01%
+75,372
New +$41.5K
ADIL
3934
Adial Pharmaceuticals
ADIL
$9.61M
$40K ﹤0.01%
+32
New +$43.8K
PWCM
3935
PowerCompute, Inc. Common Stock
PWCM
$1.42M
$40K ﹤0.01%
+93
New +$47.8K
ONCY
3936
Oncolytics Biotech
ONCY
$95.5M
$40K ﹤0.01%
25,500
-209,978
-89% -$352K
RGLS
3937
DELISTED
Regulus Therapeutics
RGLS
$40K ﹤0.01%
13,340
+11,110
+498% +$28.9K
WDH
3938
Waterdrop
WDH
$359M
$40K ﹤0.01%
26,900
-369,182
-93% -$529K
XXII
3939
22nd Century Group
XXII
$1.42M
0
JSPR icon
3940
Jasper Therapeutics
JSPR
$28.7M
$39K ﹤0.01%
+1,087
New +$49K
SND icon
3941
Smart Sand
SND
$213M
$39K ﹤0.01%
11,400
-32,300
-74% -$85K
XTIA icon
3942
XTI Aerospace
XTIA
$60.4M
0
ITRM
3943
DELISTED
Iterum Therapeutics
ITRM
$38K ﹤0.01%
7,207
-1,273
-15% -$7.36K
NEPT
3944
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$38K ﹤0.01%
122
-199
-62% -$90.4K
KNDI
3945
Kandi Technologies Group
KNDI
$64.4M
$37K ﹤0.01%
+11,500
New +$36.6K
MATH icon
3946
Metalpha Technology Holding
MATH
$38.5M
$37K ﹤0.01%
36,500
+1,500
+4% +$1.69K
PHIO icon
3947
Phio Pharmaceuticals
PHIO
$12.7M
$37K ﹤0.01%
384
+290
+309% +$27.6K
TCRX icon
3948
TScan Therapeutics
TCRX
$52.3M
$37K ﹤0.01%
+13,300
New +$57.5K
EEIQ icon
3949
EpicQuest Education Group
EEIQ
$4.08M
$36K ﹤0.01%
1,019
-394
-28% -$15.5K
SIEB icon
3950
Siebert Financial
SIEB
$78.1M
$36K ﹤0.01%
16,800
-53,600
-76% -$115K

Similar funds

Jim Simons's Q1 2022 Portfolio in Review

As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.

  • Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
  • Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
  • Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
  • Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
  • Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
  • Jim Simons opened 822 new positions and closed 650 in Q1 2022.
  • Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.